Eli Lilly and Company
Eli Lilly and Company (LLY) Revenue
Annual & quarterly revenue history · segment & region breakdown
LLY · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsEli Lilly and Company trailing twelve-month (TTM) revenue is $72.25B, an increase of 44.70% year-over-year from $65.18B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $65.18B | +$20.14B | +44.70% |
| 2024-12-31 | $45.04B | +$10.92B | +32.00% |
| 2023-12-31 | $34.12B | +$5.58B | +19.56% |
| 2022-12-31 | $28.54B | +$0.22B | +0.79% |
| 2021-12-31 | $28.32B | +$3.78B | +15.40% |
| 2020-12-31 | $24.54B | +$2.22B | +9.95% |
| 2019-12-31 | $22.32B | +$0.83B | +3.84% |
| 2018-12-31 | $21.49B | +$1.52B | +7.61% |
| 2017-12-31 | $19.97B | -$1.25B | -5.88% |
| 2016-12-31 | $21.22B | +$1.26B | +6.33% |
Compare revenue vs peers
Drug Manufacturers - GeneralCompare LLY revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Eli Lilly and Company receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Eli Lilly and Company reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Eli Lilly and Company's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
LLY revenue · 5 questionsLLY's trailing twelve-month (TTM) revenue is $72.25B. That is an increase of 44.70% year-over-year from $65.18B in FY2025.
▸ Source: FMP · Eli Lilly and Company SEC filings · GAAP · Eli Lilly and Company SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026